glp-1 egfr cut off Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Kidney function loss and albuminuria

JAMA 2024;331:3848.PubMedPMC 95

Can you switch from Semaglutide GLP-1 to tirzepatide for weight loss

Originally Developed for Diabetes: The Shift to Weight Management Originally designed for blood sugar control in type 2 diabetes, GLP-1 drugs have evolved into important therapies for obesity treatment globally

MEDVi GLP-1 Review: Telehealth Weight Loss Programs & Pricing This article is for informational purposes only and does not provide medical advice

When these problems occur theyre hard to overlook

That is, investigations are warranted to better understand the potential benefit of combined use of GLP-1 RAs and SGLT2 inhibitors in HF with specific focus on the sequence of treatment initiation and the suitable population, including by HF phenotype and presence of diabetes